Glycemic self-monitoring and insurance coverage

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 1, 2004, Pages 48-49

  Heisler, Michele ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NOTE; PREVALENCE; PUBLIC HEALTH SERVICE; TREATMENT INDICATION; UNITED STATES;

EID: 3142745137     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040681     Document Type: Note

References (13)

1. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001;16:793-9.
2. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, medication self-restriction due to cost, and outcomes among diabetes patients in three systems of care. Med Care 2004;42:102-9.
3. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
4. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med 1987;317:550-6.
5. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-7.
6. Heisler M, Wagner TH, Piette JD. Clinician identification of chronically ill patients who have problems paying for prescription medications. Am J Med 2004;16:753-8.
7. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003;290:953-8.
8. Piette JD, Heisler M, Wagner TH. Cost-Related Medication Underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med [In press].
9. Bowker SL, Mitchell CG, Majumdar SR, Toth EL, Johnson JA. Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes. CMAJ 2004;171(1):39-43.
10. Soumerai S, Mah C, Zhang F, Adams A, Barton M, Ross-Degnan D. Effects of HMO coverage of diabetes self-monitoring devices on rates of self-monitoring, medication compliance, and blood glucose control. In: Academy-Health 2002 Annual Research Meeting Abstracts. Available: www.academy-health.org/2002/abstracts/ pharmaceutical.pdf (accessed 2004 June 01).
11. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada, 1998. Diabetes Care 2002;25:1303-7.
12. The Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Pre-Assessment Diabetes Testing. May 2004, Number 34. Available: http://www.ccohta.ca/entry_e.html (accessed 2004 June 01).
13. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24:1870-7.